In addition to AVT06, which is a biosimilar candidate for Eylea ® (aflibercept) 2 mg, Alvotech is currently also developing AVT29, a biosimilar candidate for Eylea ® HD (aflibercept) 8 mg. Teva also ...

Talos Energy (TALO) announced that it has appointed Paul Goodfellow as president, CEO and a member of the Talos board of directors, effective March 1. Goodfellow is an executive with over thirty ...

ASHBURN, Va., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty ...

Founded in 1935 by Khwaja Abdul Ahmeid, Cipla operates through two segments: Pharmaceuticals and New Ventures. Cipla Limited specialises in developing medications, primarily treating respiratory ...

Rua Dr. Diogo de Faria, 1087 – 9º andar – Vila Clementino 04037-003 São Paulo/SP - Brasil E-mail: [email protected] ...

EDISON, N.J., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that has been developing a treatment for non-alcoholic ...

As per ET, the health ministry had sought the legal affairs department's view on its final draft notification on allowing small pharmaceutical companies more time for upgrading their facilities to ...

Mail Sport's racing expert Robin Goodfellow delivers his tips for Friday's meetings at Cheltenham, Newcastle, Uttoxeter, Doncaster and Wolverhampton. Newcastle Robin Goodfellow 4.04 The ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...